Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04071847 · ClinicalTrials.gov registry record
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
A clinical trial of Parkinson Disease and Essential Tremor, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 20
- Study locations
NCT04071847: Recruiting study of Parkinson Disease and Essential Tremor, sponsored by Abbott Medical Devices.
NCT04071847 is a study of Parkinson Disease and Essential Tremor that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 1,000 participants, below the 5,323-participant average among 297 other Parkinson Disease trials with a reported enrollment target (81% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04071847, a study of Parkinson Disease and Essential Tremor, is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Primary Outcome
The Movement Disorders Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) assess the severity of Parkinson's disease. This questionnaire is composed of four sections: Part I: non-motor experiences of daily living consisting of 13 questions (Part Ia is assessed by the investigator while part Ib is assessed by the subject, with or without the help of the caregiver); Part II: motor experiences of daily living consisting of 13 questions, designed to be self-administered; Part III: motor ex
Conditions Studied
Interventions
- DEVICE Deep Brain Stimulation (DBS)
Study Locations (20)
Ohio
- The Cleveland Clinic Foundation - Cleveland
- Ohio State Medical - Columbus
- Wright State University & Premier Health - Fairborn
California
- Cedars-Sinai Medical Center - Los Angeles
- University of California at Davis - Sacramento
Colorado
- Colorado Neurodiagnostics - Littleton
- Neurosurgery One - Littleton
Florida
- University of Miami Hospital - Miami
- University of South Florida - Department of Neurology - Tampa
Pennsylvania
- Center for Interventional Pain & Spine - Exton
- Thomas Jefferson Department or Neurosurgery - Philadelphia
Arizona
- University of Aizona Health Sciences - Tucson
Illinois
- Rush University Medical Center - Chicago
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2019-11-26 |
| Est. Completion | 2030-09 |
What NCT04071847 shows while recruiting
NCT04071847 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 5,323-participant average among 297 other Parkinson Disease trials with a reported enrollment target (81% lower).
The record links to 7 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation (DBS) is the first listed.
NCT04071847 names 20 study sites across 14 states, led by Ohio, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT04071847 about?
NCT04071847 is a clinical study titled "Abbott DBS Post-Market Study of Outcomes for Indications Over Time". The purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
What is the current status of trial NCT04071847?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2019-11-26. Estimated completion is 2030-09.
What conditions does trial NCT04071847 study?
This clinical trial studies the following conditions: Parkinson Disease, Essential Tremor, Dystonia, Movement Disorders, Tremor.
What interventions are being tested in trial NCT04071847?
The interventions under investigation include: Deep Brain Stimulation (DBS) (DEVICE).
Who is sponsoring clinical trial NCT04071847?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04071847 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04071847's enrollment target sits among peer trials
1,000 12th of 297 higher than 282 of 297 other Parkinson Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of Correlation Between Oculometric Measures and Clinical Assessment in Parkinson's Disease
RECRUITING · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
University of Delaware Parkinson's Disease Registry
RECRUITING
-
Neocortical Microarchitecture of Executive Function
RECRUITING · NA
-
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RECRUITING · NA
-
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI